2014

Chiltern Announces Investment in Endpoint

LONDON, March 31 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO) announced a strategic partnership with endpoint. With this investment, Chiltern becomes a minority shareholder in the company established in April 2009.

Glenn Kerkhof, Chiltern CEO, stated, "Chiltern's decision to invest in endpoint is representative of our commitment to seek collaborations which connect Chiltern and our clients with leading edge solutions as well as our belief in the technology that endpoint has developed. Jon Dole and Tom O'Connell are bringing a new level of energy and innovation to Interactive Response Technology services to provide solutions which are meeting clients' needs for flexibility, efficiency and savings while ensuring the highest possible quality. We believe that endpoint has listened - and is responding - to the industry's needs for IVR/IWR solutions and we look forward to introducing endpoint to our customers as a Chiltern qualified vendor that will meet their needs and exceed their expectations in a manner that mirrors Chiltern's commitment to the same."

Jonathan Dole, endpoint CEO, stated, "Chiltern's enthusiasm and investment affirms our confidence in the solutions we are bringing to the marketplace. At endpoint, we are delighting our clients with approaches that are exceeding their needs. Our experience in the IVR/IWR space, coupled with a fresh and logical approach to systems development, is giving our customers the agility they need in a constantly changing R&D environment. We are very pleased to be working closely with Chiltern to identify and act on opportunities for synergies across our two organizations."

PULSE, endpoint's fully configurable system that allows users to design and deploy clinical trial IRT systems at a fraction of the time and cost of other providers, was launched in January of this year. Providing both high speed of deployment and flawless quality, PULSE simultaneously designs systems that can be accessed via the phone, web, or mobile device.  

Company profiles

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information is available at www.chiltern.com.

About endpoint:

endpoint is an innovative company dedicated to the development of the leading Interactive Response Technology (IVR/IWR) platforms for the life sciences industry. endpoint's founding team members have been developing IRT systems for clinical trials since 1998 and have deployed systems to small, medium and large pharma and biotech companies for domestic and global  studies with experience across a broad range of therapeutic areas and global implementations. www.endpointclinical.com

For More Information Contact:




Natalie Chong

Sue Ojanen

Marketing Director

Marketing Associate

Chiltern International Ltd.

Chiltern International Inc.

171 Bath Road

1241 Volunteer Parkway

Slough

Suite 950

Berkshire SL1 4AA

Bristol, TN 37620

UNITED KINGDOM

USA

Tel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533

Fax: +44 (0) 1753 511 116

Fax: +1 (423) 968 3567

Email: natalie.chong@chiltern.com

Email: sue.ojanen@chiltern.com



endpoint Contact :



Rich Mullikin, APR


Marketing Director


endpoint


690 Texas Street


San Francisco, CA 94107


USA


Tel: +1 (925) 779 9115


Email: rmullikin@endpointclinical.com




SOURCE Chiltern



RELATED LINKS
http://www.chiltern.com
http://www.endpointclinical.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.